Presentation: Kava pilot phase 2 design (easing the restrictions on the commercial importation of kava)

Presentation slides from the webinar on 4 November 2020 to ensure that the Departments of Health, and Foreign Affairs and Trade consult widely on the implementation of Phase 2 of the kava pilot, which would allow the commercial importation of kava into Australia for non-therapeutic purposes.

The Prime Minister announced the kava pilot in October 2019, and it is due to be implemented by the end of 2021. A public consultation paper on Phase 2 of the pilot was opened for comment between March and May this year, but further consultation is needed to ensure that all stakeholders have had the opportunity to comment.

Community and health organisations with an interest in the effects that kava importation may have on the Australian community.

• When: Wednesday 4 November 2020
• Time: 2 - 4 pm
• Location: Online

Disclaimer: These presentation papers are provided on the ODC's website solely for the purpose of indicating or suggesting what ODC representatives spoke about to the various conferences and seminars to which it relates. The papers are not legislative in nature and should not be taken to be statements of any law or policy in any way. The Australian Government Department of Health (of which the ODC is a part) advises that (a) the presentation papers should not be relied upon in any way as representing a comprehensive description of regulatory requirements, and (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation paper.

• Presented by: George Masri, Assistant Secretary, Regulatory Services and Drug Control Branch, Regulatory Practice and Support Division, Department of Health
• Presented at: Webinar
• Presentation date: 4 November 2020